This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Esther Quecedo, MD
Department of Dermatology Hospital General Universitario Avd Tres Cruces s/n 46014 Valencia, Spain

Onofre Sanmartín, MD; M. Isabel Febrer, MD; Jorge A. Martínez-Escribano, MD; Vicente Oliver, MD; Adolfo Aliaga, MD
Valencia

Arch Dermatol. 1996;132(3):349-350.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Arsenic poisoning (AP) was once common. Arsenic's easy availability and organoleptic characteristics (tasteless and odorless) made it the most commonly employed element in criminal poisonings. As well, arsenic was frequently used in medicine to treat many diseases, such as psoriasis, syphilis, verruca plana, lichen planus, and epilepsy. Although its use is presently much more restricted, arsenic still remains a problem, and many cases of poisoning, whether accidental, industrial, or intentional are reported yearly. However, the clinical manifestations may appear unrecognized for clinicians who are not familiar with AP. Dermatologic manifestations are prominent in most cases of AP, and its knowledge may provide us the key to the diagnosis of AP. Mees' lines are true transverse bands of leukonychia seen during AP. However, they are seldom demonstrated in these patients.

In the last 8 years, we have seen four cases of AP, three of them with prominent Mees' lines, which constituted . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?